Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Companies Take Strict Measures to Prevent Flu Infections
June 1, 2009
- Kaken: Profits Up for the 7th Year Running
June 1, 2009
- BUSINESS NEWS IN BRIEF
June 1, 2009
- Mochida: Epadel, Atelec Drive Sales
June 1, 2009
- REGULATORY NEWS IN BRIEF
June 1, 2009
- Kissei: Urief, Glufast Drive Business
June 1, 2009
- PIII Trial of Amitiza for CIC Initiated in Japan: Sucampo, Abbott
June 1, 2009
- Nippon Shinyaku: Eviprostat, Intellectual Properties Bolster Business
June 1, 2009
- R&D NEWS IN BRIEF
June 1, 2009
- Otsuka HD: Sales of Healthcare Products Up to ¥676.7 Bil.
June 1, 2009
- GENERICS NEWS IN BRIEF
June 1, 2009
- Zeria: Mid-Term Sales Target Down to ¥73 Bil.
June 1, 2009
- Quintiles Named Most Favored CRO in 2 Independent Surveys
June 1, 2009
- ASKA: Profits Plummet with Flat Sales
June 1, 2009
- 60% of Patients Prefer In-House Prescriptions at Sanjou Hospital
June 1, 2009
- Seikagaku: Sales of Artz Up in Japan, China
June 1, 2009
- Cumulative Total of 787 Deaths Reported in Iressa-Treated Patients
June 1, 2009
- Nippon Chemiphar: Profits Sinks as Sales of Generics Increase
June 1, 2009
- Draft Report on Proper Preparation, Use of Fertilized Human Embryos Approved
June 1, 2009
- Rush of Orders on Gargles, Masks
June 1, 2009
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…